Dennis Huang is the Chief Technical Operations Officer and Executive Vice President of Gene Therapy at Ultragenyx. With a robust background in life sciences, he has played a pivotal role in advancing the company's technical operations and gene therapy initiatives. His leadership continues to drive Ultragenyx's mission to develop treatments for rare and ultra-rare diseases.
Who is the CTO of Ultragenyx?
With a career spanning several decades in the biotechnology sector, Dennis Huang currently serves as the Chief Technical Operations Officer and Executive Vice President of Gene Therapy at Ultragenyx. Before joining Ultragenyx in 2015, he held significant roles at various renowned companies, including InterMune Inc., Allergan, Novartis, Genentech, and Synergen. His extensive experience encompasses leading global manufacturing, supply chain activities, and biologics development. At Ultragenyx, Huang is instrumental in driving the gene therapy platform strategy, overseeing technical operations, and spearheading research and product development efforts aimed at treating rare and ultra-rare diseases.
Work History
Dennis Huang's extensive work history in the biotechnology and pharmaceutical sectors includes a variety of significant roles:
- Ultragenyx Pharmaceutical Inc. - Chief Technical Operations Officer; EVP Gene Therapy (2015 - Present)
- MassBio - Member Board of Directors (2023 - Present)
- Ornovi - Member Board Of Directors (2021 - Present)
- CYTODEL LLC - Member Board of Directors (2019 - Present)
- Bonti - Member Board of Directors (2015 - 2018)
- InterMune - Senior Vice President, Mfg Operations and Supply Chain (2013 - 2015)
- Allergan - Vice President, Biologics Mfg and Development (2006 - 2013)
- Novartis - Senior Director, Mfg Ops (2003 - 2006)
- Chiron Corporation - Director / Associate Director; Bulk Drug Mfg Operations (2001 - 2003)
- Genentech - Manager, Purification (1997 - 2001)
- Genentech - Senior Supervisor, QC (1994 - 1997)
- Synergen Inc - Bioprocess Supervisor / Research Associate (1991 - 1994)
Education History
Dennis Huang's educational background is both diverse and robust, laying a strong foundation for his illustrious career in biotechnology and pharmaceuticals. He earned a Bachelor of Arts in Chemistry from Knox College, where he developed a solid understanding of the scientific principles that would later underpin his professional endeavors. Further enhancing his expertise, Huang completed a Certificate of Professional Achievement in Operations and Technology from Kellogg Executive Education. This combination of a strong scientific foundation and advanced training in operations and technology has equipped him with the skills necessary to excel in his various leadership roles.
When did Dennis Huang join Ultragenyx?
Joining Ultragenyx in January 2015, Dennis Huang has been a pivotal figure in the company's growth and innovation. As the Chief Technical Operations Officer and Executive Vice President of Gene Therapy, he has been instrumental in advancing Ultragenyx's technical operations and gene therapy initiatives. Over his eight-year tenure, Huang has leveraged his extensive experience in the biotechnology sector to drive the company's mission of developing treatments for rare and ultra-rare diseases. His leadership continues to shape the strategic direction and operational excellence of Ultragenyx, ensuring the company remains at the forefront of biopharmaceutical innovation.